morphometry software ip lab (scanalytics inc)
90
Structured Review
scanalytics inc
morphometry software ip lab
Morphometry Software Ip Lab, supplied by scanalytics inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/ip+lab+software/morphometry+software+ip+lab/pm31545275-95-19-23
Average 90 stars, based on 1 article reviews
Morphometry Software Ip Lab, supplied by scanalytics inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/ip+lab+software/morphometry+software+ip+lab/pm31545275-95-19-23
Average 90 stars, based on 1 article reviews
morphometry software ip lab - by Bioz Stars,
2026-11
90/100 stars
Images
Related Articles
Software:Article Title: A novel therapy for hepatic cholestasis treatment-the combination of rosiglitazone and fenofibrate. Article Snippet: Hepatic cholestasis can develop into liver fibrosis and eventually liver failure.. Currently, ursodeoxycholic acid (UDCA) or UDCA combined with fenofibrate is used for cholestasis treatment.. Rosiglitazone inhibited α-naphthyl isothiocyanate (ANIT)-induced cholestasis in mice. Article Title: Food with calorie restriction reduces the development of atherosclerosis in apoE-deficient mice. Article Snippet: Calorie restriction (CR) ameliorates various diseases including cardiovascular disease.. However, its protection and underlying mechanisms against atherosclerosis remain un-fully elucidated.. In this study, we fed apoE deficient (apoE /-) mice in Control group a high-fat diet (HFD, 21% fat plus 0.5% cholesterol) or in CR group a CR diet (CRD, 2% fat plus 0.5% cholesterol, ~40% calorie restriction and same levels of cholesterol, vitamins, minerals and amino acids as in HFD). Article Title: Ascorbic acid enhances low-density lipoprotein receptor expression by suppressing proprotein convertase subtilisin/kexin 9 expression Article Snippet: .. After capture, the mean fluorescence intensity (MFI) of all immunofluorescent images was calculated as described (40) using Article Title: Discovery of Novel Pterostilbene Derivatives That Might Treat Sepsis by Attenuating Oxidative Stress and Inflammation through Modulation of MAPKs/NF-κB Signaling Pathways Article Snippet: .. The density of each captured image was quantified by a technician (blinded to the treatments) with segmentation colour-threshold analysis using Article Title: Local, Downstream, and Systemic Evaluation after Femoral Artery Angioplasty with Kanshas Drug-Coated Balloons In Vitro and in a Healthy Swine Model. Article Snippet: Purpose: To evaluate the incidence of distal embolism and local vascular responses after treatment with the Kanshas drugcoated balloon (DCB) in a preclinical model. Materials and Methods: A total of 90 femoral arteries from 35 healthy swine were treated with a single-dose (×1) or tripledose (×3) Kanshas DCB that applies the Unicoat technology with 3.2 μg/mm of paclitaxel.. An uncoated Kanshas balloon was used as a control.. The arterial wall, downstream skeletal muscle, and nontarget organs (kidneys, lungs, lymph nodes, liver, spleen, and heart) were histologically evaluated. Article Title: Procyanidin B2 Reduces Vascular Calcification through Inactivation of ERK1/2-RUNX2 Pathway Article Snippet: .. The mean fluorescence intensity (MFI) of all immunofluorescent images was calculated as described in [ ] using Article Title: Apigenin protects mice against 3,5-diethoxycarbonyl-1,4-dihydrocollidine-induced cholestasis. Article Snippet: Cholestasis can induce liver fibrosis and cirrhosis.. Apigenin has anti-oxidant and anti-inflammatory effects.. Herein, we determined whether apigenin can protect mice against cholestasis. Article Title: Polysaccharide MCP extracted from Morchella esculenta reduces atherosclerosis in LDLR-deficient mice. Article Snippet: The pharmaceutical application of fungal polysaccharides has been extensively studied based on their multiple biological activities.. However, the effect of Morchella esculenta polysaccharides on the development of atherosclerosis remains unknown.. This study aims to investigate the anti-atherosclerotic effect of a novel polysaccharide (MCP) extracted from Morchella esculenta. Fluorescence:Article Title: Ascorbic acid enhances low-density lipoprotein receptor expression by suppressing proprotein convertase subtilisin/kexin 9 expression Article Snippet: .. After capture, the mean fluorescence intensity (MFI) of all immunofluorescent images was calculated as described (40) using Article Title: Procyanidin B2 Reduces Vascular Calcification through Inactivation of ERK1/2-RUNX2 Pathway Article Snippet: .. The mean fluorescence intensity (MFI) of all immunofluorescent images was calculated as described in [ ] using Article Title: Polysaccharide MCP extracted from Morchella esculenta reduces atherosclerosis in LDLR-deficient mice. Article Snippet: The pharmaceutical application of fungal polysaccharides has been extensively studied based on their multiple biological activities.. However, the effect of Morchella esculenta polysaccharides on the development of atherosclerosis remains unknown.. This study aims to investigate the anti-atherosclerotic effect of a novel polysaccharide (MCP) extracted from Morchella esculenta. Staining:Article Title: Apigenin protects mice against 3,5-diethoxycarbonyl-1,4-dihydrocollidine-induced cholestasis. Article Snippet: Cholestasis can induce liver fibrosis and cirrhosis.. Apigenin has anti-oxidant and anti-inflammatory effects.. Herein, we determined whether apigenin can protect mice against cholestasis. Article Title: Polysaccharide MCP extracted from Morchella esculenta reduces atherosclerosis in LDLR-deficient mice. Article Snippet: The pharmaceutical application of fungal polysaccharides has been extensively studied based on their multiple biological activities.. However, the effect of Morchella esculenta polysaccharides on the development of atherosclerosis remains unknown.. This study aims to investigate the anti-atherosclerotic effect of a novel polysaccharide (MCP) extracted from Morchella esculenta. Western Blot:Article Title: Polysaccharide MCP extracted from Morchella esculenta reduces atherosclerosis in LDLR-deficient mice. Article Snippet: The pharmaceutical application of fungal polysaccharides has been extensively studied based on their multiple biological activities.. However, the effect of Morchella esculenta polysaccharides on the development of atherosclerosis remains unknown.. This study aims to investigate the anti-atherosclerotic effect of a novel polysaccharide (MCP) extracted from Morchella esculenta. Lysis:Article Title: Polysaccharide MCP extracted from Morchella esculenta reduces atherosclerosis in LDLR-deficient mice. Article Snippet: The pharmaceutical application of fungal polysaccharides has been extensively studied based on their multiple biological activities.. However, the effect of Morchella esculenta polysaccharides on the development of atherosclerosis remains unknown.. This study aims to investigate the anti-atherosclerotic effect of a novel polysaccharide (MCP) extracted from Morchella esculenta. Expressing:Article Title: Polysaccharide MCP extracted from Morchella esculenta reduces atherosclerosis in LDLR-deficient mice. Article Snippet: The pharmaceutical application of fungal polysaccharides has been extensively studied based on their multiple biological activities.. However, the effect of Morchella esculenta polysaccharides on the development of atherosclerosis remains unknown.. This study aims to investigate the anti-atherosclerotic effect of a novel polysaccharide (MCP) extracted from Morchella esculenta. Marker:Article Title: Polysaccharide MCP extracted from Morchella esculenta reduces atherosclerosis in LDLR-deficient mice. Article Snippet: The pharmaceutical application of fungal polysaccharides has been extensively studied based on their multiple biological activities.. However, the effect of Morchella esculenta polysaccharides on the development of atherosclerosis remains unknown.. This study aims to investigate the anti-atherosclerotic effect of a novel polysaccharide (MCP) extracted from Morchella esculenta. |